HAVCR2 and hepatocellular carcinoma: Interestingly, the percentage of PD-1+ CD8+ and TIM-3+ CD8+ T cells displayed little difference between WT and KO mice under anti-F4/80 antibody treatment for HCC (Fig. 2d).